darunavir has been researched along with Liver Dysfunction in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arya, V; Au, S; Mullick, C; Struble, K; Wagner, C; Zhao, P | 1 |
De Paepe, E; De Pauw, M; Hoetelmans, RM; Sekar, V; Spinosa-Guzman, S; Stevens, T; Tomaka, F | 1 |
1 trial(s) available for darunavir and Liver Dysfunction
Article | Year |
---|---|
Pharmacokinetics of multiple-dose darunavir in combination with low-dose ritonavir in individuals with mild-to-moderate hepatic impairment.
Topics: Adult; Darunavir; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; HIV Protease Inhibitors; Humans; Liver Diseases; Male; Middle Aged; Ritonavir; Sulfonamides | 2010 |
2 other study(ies) available for darunavir and Liver Dysfunction
Article | Year |
---|---|
Physiologically Based Pharmacokinetic Modeling for Predicting the Effect of Intrinsic and Extrinsic Factors on Darunavir or Lopinavir Exposure Coadministered With Ritonavir.
Topics: Adult; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Darunavir; Drug Interactions; Female; Healthy Volunteers; HIV Protease Inhibitors; Humans; Liver Diseases; Lopinavir; Male; Middle Aged; Models, Biological; Ritonavir; Young Adult | 2017 |
Liver toxicity warning for darunavir.
Topics: Chemical and Drug Induced Liver Injury; Darunavir; Drug Labeling; HIV Protease Inhibitors; Humans; Liver; Liver Diseases; Sulfonamides; United States; United States Food and Drug Administration | 2008 |